News

First came the mounting tension in the shoulders and the weakening grip while carrying 25-pound weights (11.3 kilograms). Welcome to the workout routine for two-time IndyCar series champion Josef ...
Last week we experienced another volatile Bessent Bounce. Maybe this one can be the confirmation of a reversal in bearish ...
Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...
Quantum Computing remains a speculative photonic bet, with upside on chip orders and downside on delivery risk. Check out why ...
Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...
Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.
It is sad to see pets die of something easily preventable. It's even worse knowing that the owner was misinformed or misled ...
Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...
Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...
The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...
Applications to speak at Disrupt 2025 on October 27–29 at Moscone West in San Francisco. Share your insights with 10,000+ ...
Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...